{
    "code": "02023323",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023323",
    "time": "2019-08-23 03:03:33",
    "許可證字號": "衛署藥輸字第023323號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/12\/05",
    "發證日期": "90\/12\/05",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202332305",
    "中文品名": "帝盟多膠囊２０毫克",
    "英文品名": "TEMODAL CAPSULES 20MG",
    "適應症": "新診斷的多型性神經膠母細胞瘤，與放射線治療同步進行，然後作為輔助性治療。給予標準治療後復發性或惡化之惡性神經膠質瘤，例如多型神經膠母細胞瘤或退行性星狀細胞瘤。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000顆玻璃瓶裝 鋁箔小袋裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "TEMOZOLOMIDE",
    "主製造廠": {
        "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
        "申請商地址": "台北市信義區信義路五段106號12樓",
        "主製造廠": "",
        "製造廠名稱": "FFI0019000  ORION CORPORATION"
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FBE0006000  SCHERING-PLOUGH LABO N.V.",
            "製造廠廠址": "INDUSTRIEPARK,30,B-2220 HEIST-OP-DEN-BERG BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002000",
            "成分名稱": "TEMOZOLOMIDE",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "02023323_Temodal_中文仿單_201706-106-07-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023323&Seq=003&Type=9"
        },
        {
            "title": "02023323_foil_20170520-106-06-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023323&Seq=004&Type=8"
        },
        {
            "title": "02023323_carton_20170620-106-06-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023323&Seq=003&Type=8"
        }
    ]
}